Hydracarbazine
Hydracarbazine
Hydracarbazine (pronounced: hy-dra-car-ba-zine) is a type of chemotherapy drug used in the treatment of various types of cancer.
Etymology
The term "Hydracarbazine" is derived from the Greek words "hydro" meaning water, "carbo" meaning carbon, and "azine" referring to a class of organic compounds.
Usage
Hydracarbazine is used in the treatment of Hodgkin's disease, non-Hodgkin's lymphoma, and other types of leukemia. It works by slowing or stopping the growth of cancer cells in the body.
Side Effects
Like all chemotherapy drugs, Hydracarbazine can cause side effects, including nausea, vomiting, loss of appetite, and hair loss. More serious side effects can include anemia, neutropenia, and thrombocytopenia.
Related Terms
- Chemotherapy: A type of cancer treatment that uses drugs to destroy cancer cells.
- Hodgkin's disease: A type of lymphoma, which is a blood cancer that starts in the lymphatic system.
- Non-Hodgkin's lymphoma: A type of lymphoma that is not Hodgkin's disease.
- Leukemia: A type of cancer of the blood cells.
- Anemia: A condition in which the body does not have enough healthy red blood cells.
- Neutropenia: A condition characterized by a low number of neutrophils, a type of white blood cell.
- Thrombocytopenia: A condition in which you have a low blood platelet count.
External links
- Medical encyclopedia article on Hydracarbazine
- Wikipedia's article - Hydracarbazine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski